Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in equity...

UA Multimedia Announces Leadership Transition and Change of Control

UA Multimedia Announces Leadership Transition and Change of Control

Key Highlights: Leadership Transition and Strategic VisionUA Multimedia, Inc. (OTC: UAMM) has appointed fintech leader Nathan Ho as its new CEO, succeeding Huan Nguyen. This leadership change, combined with Professor Thanh Phan's appointment as the sole director,...

Ep3Oil, Inc. Announces Letter To Shareholders

Ep3Oil, Inc. Announces Letter To Shareholders

Plant City, Florida, March 24, 2025 - PRISM MediaWire - Ep3Oil, Inc. (OTC: EEEP) (“the Company ''), is an Independent oil and gas company operating in the Oil and Gas sector. It is pleased to announce a communication to its shareholders and interested parties. Dear...

JP3E Holdings Inc establishes Datang International Trading Co. Ltd as Joint Venture in South Korea with China Datang Holdings Group Corp. Ltd, Acquiring JP3E Preferred Shares, Providing Funding to Facilitate $2,800,000,000 in Copper and Gold Sales, agreeing to extend to LNG trading worldwide

JP3E Holdings Inc establishes Datang International Trading Co. Ltd as Joint Venture in South Korea with China Datang Holdings Group Corp. Ltd, Acquiring JP3E Preferred Shares, Providing Funding to Facilitate $2,800,000,000 in Copper and Gold Sales, agreeing to extend to LNG trading worldwide

This funding resolves the sole historical obstacle to closing these formidable transactions Audio Overview: https://soundcloud.com/thomas-wolff-310172965/jp3e SOMERSET, N.J., March 20, 2025 - PRISM MediaWire - JP 3E Holdings, Inc. (“JP3E”) formerly Spooz, Inc. (OTC:...